ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2618

Population Health Management for Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network

Julia Harris1, Catherine Bingham2, Sheetal Vora3, Cagri Yildirim-Toruner4, Kerry Ferraro5, Erik Friedrichsen6, Danielle Bullock7, Jon Burnham8, Tzielan Lee9, Daniel Lovell10, Ted Wimmel11, Delores Mincarelli11, Mayur Patil12, Magen Phillips11 and Esi Morgan13, 1Children's Mercy Kansas City, Overland Park, KS, 2Penn State Children’s Hospital, Hershey, 3Atrium Health Levine Children's Hospital, Charlotte, NC, 4Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 5JIA parent and CHOP volunteer, Lower Gwynedd, PA, 6Seattle Children's Hospital, Seattle, 7M Health Fairview Masonic Children’s Hospital, Minneapolis, 8Children's Hospital of Philadelphia, Philadelphia, PA, 9Stanford University School of Medicine, Palo Alto, CA, 10Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 11Hive Networks, Newport, 12VSquare Infotech Inc, Edison, NJ, 13Seattle Children's Hospital, Seattle, WA

Meeting: ACR Convergence 2024

Keywords: Juvenile idiopathic arthritis, Pediatric rheumatology, quality of care, registry

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: Measures & Measurement of Healthcare Quality

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a learning health network with a vision that children with rheumatic disease will have excellent health outcomes under the care of highly effective pediatric rheumatology teams. PR-COIN has initially focused its work on juvenile idiopathic arthritis (JIA) and hosts a shared patient registry utilizing Hive Networks platform. PR-COIN incorporates population health management (PHM) as a strategy to improving outcomes in patients with JIA. PR-COIN worked with Hive Networks to create a population management tool to enhance PHM both at the collaborative and site level.

Methods: The PR-COIN registry has collected JIA patient data from 2011 to present. Data can be stratified by demographic variables, JIA subtype, diagnosis date, provider, disease activity metrics, patient-reported outcome variables, medications, labs, and adverse events. The PR-COIN Measures Committee has been working with Hive Networks since 2022 to create a quality measure dashboard and other functionality. PR-COIN and Hive Networks are working together to optimize the approach to PHM.

Results: The population management tool (Figure 1) was created in the PR-COIN registry to assist sites in closing quality of care gaps for their active patients with JIA in the registry (13,500 total patients in registry and 7,393 active patients). The summary screen functionality includes dynamic filtering and the ability to drill down to the patient level at individual PR-COIN sites. This tool allows for identification of patients with high disease activity by assessing lists of patients with high clinical Juvenile Arthritis Disease Activity Score values, high active joint counts, active systemic features (in patients with systemic JIA), and active uveitis, for example. It can also track patients lost to follow-up based on the “months from last visit” variable. Furthermore, the tool can aid in optimizing data quality by assessing variables that are “unknown” or “not reported.” The population management tool also allows for tracking of the patient population stratified by the same variables over time (Figure 2). This allows sites to assess their population performance for different disease activity states, in addition to stratifying their population by demographics and JIA subtype for future quality improvement or research studies.

Conclusion: PHM is an important aspect of the care for patients with chronic diseases. The PR-COIN population management tool can be used to understand characteristics and status of the entire clinic population and to identify and address individual patients with gaps in care to improve measures performance and outcomes for all patients with JIA.

Supporting image 1

Figure 1. Population Management Tool Summary.

Supporting image 2

Figure 2. Example Chart of the Population Management Stratification Variable Tool.


Disclosures: J. Harris: None; C. Bingham: None; S. Vora: None; C. Yildirim-Toruner: None; K. Ferraro: None; E. Friedrichsen: None; D. Bullock: None; J. Burnham: None; T. Lee: None; D. Lovell: AstraZeneca, 12, Consultant, money paid to employer, not individual, Bristol-Myers Squibb(BMS), 5, 12, Contract, money paid to employer, not individual, GlaxoSmithKlein(GSK), 12, Consultant, money paid to employer, not individual, Janssen, 12, Contract, money paid to employer, not individual, Novartis, 12, Consultant, money paid to employer, not individual, Pfizer, 12, DSMB, money paid to employer, not individual, 12, Consultant, money paid to employer, not individual, Roche, 12, Contract, money paid to employer, not individual, United Bioscience Corporation, 12, Consultant, money paid to employer, not individual; T. Wimmel: Hive Networks, 3; D. Mincarelli: Hive Networks, 3; M. Patil: Hive Networks, 2, VSquare Infotech Inc, 3; M. Phillips: Hive Networks, 3; E. Morgan: Pfizer, 5.

To cite this abstract in AMA style:

Harris J, Bingham C, Vora S, Yildirim-Toruner C, Ferraro K, Friedrichsen E, Bullock D, Burnham J, Lee T, Lovell D, Wimmel T, Mincarelli D, Patil M, Phillips M, Morgan E. Population Health Management for Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/population-health-management-for-juvenile-idiopathic-arthritis-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/population-health-management-for-juvenile-idiopathic-arthritis-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology